Harmony Biosciences: Q1 Earnings Insights

Harmony Biosciences: Q1 Earnings Insights


Harmony Biosciences HRMY reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.


Harmony Biosciences beat estimated earnings by 75.86%, reporting an EPS of $0.51 versus an estimate of $0.29.

Revenue was up $25.64 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.26 which was followed by a 0.25% increase in the share price the next day.

Here's a look at Harmony Biosciences's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.37 0.28 0.18 -0.03
EPS Actual 0.63 0.51 0.54 0.38
Revenue Estimate 90.01M 79.85M 68.77M 57.07M
Revenue Actual 91.21M 80.73M 73.82M 59.67M

To track all earnings releases for Harmony Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarningsNews